Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128916) titled 'XR+AI Kidney Tumor Surgery Planning System' on July 28.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Ningbo University?
Condition:
Clear cell renal cancer
Intervention:
Experimental group:Utilize the XR+AI kidney tumor surgery planning system
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Experimental group:25;Control group:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334190
Published by HT Digital Content Services with permis...